Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DR26FY7WQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,645
Award facts
- Contract value 100% obligated
- $18,645.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,645.40 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose auto-injector pens on October 20, 2025, with completion scheduled for October 21, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to deliver a broad portfolio of pharmaceutical products and medical supplies globally to support military healthcare programs.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Cosentyx is a specialty immunosuppressant medication used to treat autoimmune and inflammatory conditions, representing the type of specialized pharmaceutical products that fall within the company's extensive federal contract portfolio. This delivery order exemplifies the ongoing pharmaceutical supply operations conducted through DLA's medical supply chain, supporting the department's healthcare mission through established vendor relationships with major pharmaceutical distributors capable of meeting federal medical requirements.
Quick answers
Who was awarded contract SPE2DR26FY7WQ?
SPE2DR26FY7WQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DR26FY7WQ worth?
The government has obligated $18,645 on SPE2DR26FY7WQ.
Is contract SPE2DR26FY7WQ an order under another contract?
Yes. SPE2DR26FY7WQ is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY7WQ competed?
The extent of competition for SPE2DR26FY7WQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award